Psychedelic Psychiatry

por Nutt, D.
Publicado 2022

Introduction. The neurobiology of drug addiction: new vistas

por Robbins, T.W, Everitt, B.J, Nutt, D.J
Publicado 2008

Generalized teleparallel de Sitter geometries

por Coley, A. A., Landry, A., van den Hoogen, R. J., McNutt, D. D.
Publicado 2023

Psychopharmacological characterisation of the successive negative contrast effect in rats

por Phelps, C. E., Mitchell, E. N., Nutt, D. J., Marston, H. M., Robinson, E. S. J.
Publicado 2015

Resilienz gegen IT-Angriffe an Kliniken: Ergebnisse einer Stabsrahmenübung an einem Universitätsklinikum

por Pfenninger, E. G., Schmidt, S. A., Rohland, C., Peters, S., McNutt, D., Kaisers, U. X., Königsdorfer, M.
Publicado 2023

Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial

por Wiles, N. J., Fischer, K., Cowen, P., Nutt, D., Peters, T. J., Lewis, G., White, I. R.
Publicado 2014

Homological scaffolds of brain functional networks

por Petri, G., Expert, P., Turkheimer, F., Carhart-Harris, R., Nutt, D., Hellyer, P. J., Vaccarino, F.
Publicado 2014

Effects of psilocybin therapy on personality structure

por Erritzoe, D., Roseman, L., Nour, M. M., MacLean, K., Kaelen, M., Nutt, D. J., Carhart‐Harris, R. L.
Publicado 2018

Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression

por Stroud, J. B., Freeman, T. P., Leech, R., Hindocha, C., Lawn, W., Nutt, D.J., Curran, H.V, Carhart-Harris, R. L.
Publicado 2017

Neural substrates of cue reactivity and craving in gambling disorder

por Limbrick-Oldfield, E H, Mick, I, Cocks, R E, McGonigle, J, Sharman, S P, Goldstone, A P, Stokes, P R A, Waldman, A, Erritzoe, D, Bowden-Jones, H, Nutt, D, Lingford-Hughes, A, Clark, L
Publicado 2017

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

por Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., Rickard, J. A., Forbes, B., Feilding, A., Taylor, D., Curran, H. V., Nutt, D. J.
Publicado 2017

Innovative solutions to novel drug development in mental health

por Insel, T.R., Voon, V., Nye, J.S., Brown, V.J., Altevogt, B.M., Bullmore, E.T., Goodwin, G.M., Howard, R.J., Kupfer, D.J., Malloch, G., Marston, H.M., Nutt, D.J., Robbins, T.W., Stahl, S.M., Tricklebank, M.D., Williams, J.H., Sahakian, B.J.
Publicado 2013

Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery

por Savulich, G, Riccelli, R, Passamonti, L, Correia, M, Deakin, J F W, Elliott, R, Flechais, R S A, Lingford-Hughes, A R, McGonigle, J, Murphy, A, Nutt, D J, Orban, C, Paterson, L M, Reed, L J, Smith, D G, Suckling, J, Tait, R, Taylor, E M, Sahakian, B J, Robbins, T W, Ersche, K D
Publicado 2017